1ad0: Difference between revisions

Revision as of 16:35, 30 June 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:1ad0.png

Template:STRUCTURE 1ad0

FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7

Template:ABSTRACT PUBMED 9329081

About this StructureAbout this Structure

1AD0 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

VL:VH domain rotations in engineered antibodies: crystal structures of the Fab fragments from two murine antitumor antibodies and their engineered human constructs., Banfield MJ, King DJ, Mountain A, Brady RL, Proteins. 1997 Oct;29(2):161-71. PMID:9329081

Page seeded by OCA on Mon Jun 30 16:35:50 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:1ad0.jpg|left|200px]]
+{{Seed}}
+[[Image:1ad0.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_1ad0|  PDB=1ad0  |  SCENE=  }}
-'''FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7'''
+===FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7===
-==Overview==
+<!--
-The crystal structures of two pairs of Fab fragments have been determined. The pairs comprise both a murine and an engineered human form, each derived from the antitumor antibodies A5B7 and CTM01. Although antigen specificity is maintained within the pairs, antigen affinity varies. A comparison of the hypervariable loops for each pair of antibodies shows their structure has been well maintained in grafting, supporting the canonical loop model. Detailed structural analysis of the binding sites and domain arrangements for these antibodies suggests the differences in antigen affinity observed are likely to be due to inherent flexibility of the hypervariable loops and movements at the VL:VH domain interface. The four structures provide the first opportunity to study in detail the effects of protein engineering on specific antibodies.
+The line below this paragraph, {{ABSTRACT_PUBMED_9329081}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 9329081 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_9329081}}
 ==About this Structure==
@@ Line 26: / Line 30: @@
 [[Category: Fab fragment]]
 [[Category: Immunoglobulin]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 10:06:45 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 16:35:50 2008''